Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 5/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21758540 | 0.88 | AR (0.33) | ARSMN1; SMN2ALDH1A1LMNAHPGD | |
| SCHEMBL21396755 | 0.79 | AR (0.37) | ARSMN1; SMN2ALDH1A1LMNAHPGD | |
| SCHEMBL21758353 | 0.79 | DDB1 (0.36) | ALDH1A1 | |
| SCHEMBL21758352 | 0.79 | DDB1 (0.36) | ALDH1A1 | |
| SCHEMBL21397012 | 0.78 | CNR2 (0.36) | ARSMN1; SMN2ALDH1A1LMNAHPGD | |
| SCHEMBL21758548 | 0.78 | HRH1 (0.41) | LMNAHIF1A | |
| SCHEMBL21758524 | 0.77 | PTGDR2 (0.39) | SMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL19755323 | 0.76 | KDM4E (0.41) | ARSMN1; SMN2ALDH1A1LMNAHPGD | |
| SCHEMBL22377795 | 0.76 | SMN1; SMN2 (0.37) | ARSMN1; SMN2ALDH1A1LMNAHPGD | |
| SCHEMBL24268765 | 0.75 | KDM4E (0.42) | ARSMN1; SMN2ALDH1A1LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3638749-B1 | ORGANIC MOLECULE, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2021-05-19 | — | — | EP | disclosed |
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OXER1, OR10J3, OXGR1 | AR 1322/4885SMN1; SMN2 4518/4885ALDH1A1 1610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.